Bay Street News, 2018

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development […]

EDINBURGH, United Kingdom, Nov. 20, 2018 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving […]

CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]

WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]

CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused […]

RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has […]

(All amounts in this release are in Canadian Dollars) KANATA, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) — Calian Group Ltd. […]

VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) — Silver Bull Resources, Inc. (OTCQB: SVBL, TSX: SVB) (“Silver Bull”) is […]

TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Fura Gems Inc. (TSXV: FURA, OTC: FUGMF and FRA: BJ43) (“Fura Gems” or […]

Improvement in All Operational Parameters in the Period Same property NOI growth of 2.3% compared to the same period in […]